Corrigendum to: Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction (Diabetes, Obesity and Metabolism, (2011), 13, 5, (465-473), 10.1111/j.1463-1326.2011.01369.x);Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction

Diabetes, Obesity and Metabolism

Volumn 13, Issue 5, 2011, Pages 465-473

  Roe, N D ^a   Thomas, D P ^b   Ren, J ^a  

^a UNIVERSITY OF WYOMING   (United States)

^b UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Antidiabetic drug; Cardiovascular disease; Contractile function; Diabetes; Diabetes mellitus; Myocardium; Nitric oxide

Indexed keywords

3 NITROTYROSINE; ADENYLATE KINASE; APOCYNIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 90; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PEROXYNITRITE; PHOSPHOLAMBAN; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXPERIMENTAL DIABETES MELLITUS; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HYPERGLYCEMIA; MALE; MORPHOMETRICS; MOUSE; MYOCARDIAL CONTRACTILE DYSFUNCTION; MYOCARDIAL DISEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; WESTERN BLOTTING;

EID: 79953045959     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.14828     Document Type: Erratum

References (34)

1. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Cardiovasc Drugs Ther 1994; 8: 65-73.
2. Karnik AA, Fields AV, Shannon RP. Diabetic cardiomyopathy. Curr Hypertens Rep 2007; 9: 467-473.
3. 2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme. Free Radic Biol Med 2006; 40: 1419-1429.
4. Cook SA, Aitman T, Naoumova RP. Therapy insight: heart disease and the insulin-resistant patient. Nat Clin Pract 2005; 2: 252-260.
5. Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 2001; 1: 181-193.
6. Wold LE, Ceylan-Isik AF, Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin 2005; 26: 908-917.
7. Privratsky JR, Wold LE, Sowers JR, Quinn MT, Ren J. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 2003; 42: 206-212.
8. Olukman M, Orhan CE, Celenk FG, Ulker S. Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions. J Diabetes Complications 2010; 24: 415-423.
9. Shen E, Li Y, Li Y et al. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 2009; 58: 2386-2395.
10. Guzik TJ, Mussa S, Gastaldi D et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105: 1656-1662.
11. Chen W, Druhan LJ, Chen CA et al. Peroxynitrite induces destruction of the tetrahydrobiopterin and heme in endothelial nitric oxide synthase: transition from reversible to irreversible enzyme inhibition. Biochemistry 2010; 49: 3129-3137.
12. Zou MH, Shi C, Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 2002; 109: 817-826.
13. Bers DM. Cardiac excitation-contraction coupling. Nature 2002; 415: 198-205.
14. Muijsers RB, van Ark I, Folkerts G et al. Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice. Br J Pharmacol 2001; 134: 434-440.
15. Fang CX, Dong F, Thomas DP, Ma H, He L, Ren J. Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription. Am J Physiol Heart Circ Physiol 2008; 295: H1206-H1215.
16. Dong F, Zhang X, Ren J. Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway. Hypertension 2006; 47: 222-229.
17. Li Q, Wu S, Li SY et al. Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage. Am J Physiol Heart Circ Physiol 2007; 292: H1398-H1403.
18. Giovannoni G, Land JM, Keir G, Thompson EJ, Heales SJ. Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann Clin Biochem 1997; 34(Pt 2): 193-198.
19. Li Q, Li J, Ren J. UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMP-activated protein kinase. Am J Physiol Endocrinol Metab 2009; 297: E965-E973.
20. Ceylan-Isik AF, LaCour KH, Ren J. Sex difference in cardiomyocyte function in normal and metallothionein transgenic mice: the effect of diabetes mellitus. J Appl Physiol 2006; 100: 1638-1646.
21. Itani SI, Saha AK, Kurowski TG, Coffin HR, Tornheim K, Ruderman NB. Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase. Diabetes 2003; 52: 1635-1640.
22. Kuo WW, Chung LC, Liu CT et al. Effects of insulin replacement on cardiac apoptotic and survival pathways in streptozotocin-induced diabetic rats. Cell Biochem Funct 2009; 27: 479-487.
23. Lin MI, Fulton D, Babbitt R et al. Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. J Biol Chem 2003; 278: 44719-44726.
24. Kruger M, Babicz K, von Frieling-Salewsky M, Linke WA. Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy. J Mol Cell Cardiol 2010; 48: 910-916.
25. Ma H, Li SY, Xu P et al. Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med 2009; 13: 1751-1764.
26. Brindley DN, Kok BP, Kienesberger PC, Lehner R, Dyck JR. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab 2010; 298: E897-E908.
27. Turdi S, Li Q, Lopez FL, Ren J. Catalase alleviates cardiomyocyte dysfunction in diabetes: role of Akt, Forkhead transcriptional factor and silent information regulator 2. Life Sci 2007; 81: 895-905.
28. Kruger M, Babicz K, von Frieling-Salewsky M, Linke WA. Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy. J Mol Cell Cardiol 2010; 48: 910-916.
29. Crespo MJ, Zalacain J, Dunbar DC, Cruz N, Arocho L. Cardiac oxidative stress is elevated at the onset of dilated cardiomyopathy in streptozotocin-diabetic rats. J Cardiovasc Pharmacol Ther 2008; 13: 64-71.
30. Norby FL, Wold LE, Duan J, Hintz KK, Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab 2002; 283: E658-E666.
31. 2+ depletion in cardiac myocytes. Free Radic Biol Med 2010; 48: 1182-1187.
32. Ren J, Duan J, Thomas DP et al. IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction. Am J Physiol Regul Integr Comp Physiol 2008; 294: R793-R802.
33. Youn JY, Wang T, Cai H. An ezrin/calpain/PI3K/AMPK/eNOSs1179 signaling cascade mediating VEGF-dependent endothelial nitric oxide production. Circ Res 2009; 104: 50-59.
34. Zhang Y, Ren J. Autophagy in ALDH2-elicited cardioprotection against ischemic heart disease: slayer or savior? Autophagy 2010; 6: 1212-1213.